TIDMEAH

RNS Number : 9280T

Eco Animal Health Group PLC

23 March 2023

23 March 2023

ECO Animal Health Group plc

("ECO", the "ECO Group") (AIM: EAH)

Pre-close Trading Update

ECO Animal Health Group plc, a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, is pleased to provide an update to its expected results for the year ended 31 March 2023.

The ECO Group has experienced strong trading in its final quarter and it is clear that the demand for Aivlosin has been a little stronger than expected in China and Asia. As a result, the Board now expects that Revenue and Earnings before Interest, Tax, Depreciation and Amortisation will be slightly ahead of market expectations for the current financial year.

David Hallas, CEO, noted that "Our business has delivered good progress in key international markets especially Asia. We look forward to providing a further update following the completion of the financial year."

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR") as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

For further information please contact:

 
 ECO Animal Health Group plc 
  David Hallas (CEO) 
  Christopher Wilks (CFO)                       020 8447 8899 
 
   IFC Advisory 
   Graham Herring 
   Zach Cohen                                     020 3934 6630 
 
   Singer Capital Markets (Nominated Adviser 
   & Joint Broker) 
   Philip Davies 
   George Tzimas                                  020 7496 3000 
 
   Investec (Joint Broker) 
   Gary Clarence 
   Lydia Zychowska 
   Carlo Spingardi                                020 7597 5970 
 
 
 Equity Development 
  Hannah Crowe 
  Matt Evans           020 7065 2692

About ECO Animal Health

ECO Animal Health Group plc researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TSTFLFETVDIFFIV

(END) Dow Jones Newswires

March 23, 2023 03:00 ET (07:00 GMT)

Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Eco Animal Health Charts.
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Eco Animal Health Charts.